Position in PAHC
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$28,705
+$7,169 QoQ
Shares Held
519
-67.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in PAHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026KBC Group NV holds $54,185,094 across 22 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
361,278 | $25,961,435 | |
| 2 | VTRS |
Viatris Inc
|
656,354 | $10,422,901 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
9,065 | $4,911,688 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
75,831 | $3,111,345 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
17,109 | $2,883,550 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
91,785 | $2,258,828 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
62,171 | $2,106,353 | |
| 8 | LQDA |
Liquidia Corp
|
12,930 | $1,030,908 |
All Filings in PAHC
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $28,705 | 519 | Shares | Defined | 2026-05-07 | |
| 2023-06-30 | $21,536 | 1,572 | Shares | Defined | 2024-02-15 | |
| 2023-03-31 | $24,083 | 1,572 | Shares | Defined | 2024-02-14 | |
| 2022-12-31 | $21,080 | 1,572 | Shares | Defined | 2024-02-14 | |
| 2022-09-30 | $20,891 | 1,572 | Shares | Defined | 2024-02-15 | |
| 2022-06-30 | $30,072 | 1,572 | Shares | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||